Acerus Pharmaceuticals Co. (OTCMKTS:TRLPF – Get Free Report)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.22 and traded as high as $0.22. Acerus Pharmaceuticals shares last traded at $0.22, with a volume of 0 shares changing hands.
Acerus Pharmaceuticals Price Performance
The company has a quick ratio of 0.90, a current ratio of 1.35 and a debt-to-equity ratio of 0.64. The stock has a market cap of $56.90 million, a P/E ratio of -2.75 and a beta of 2.60. The business’s 50-day simple moving average is $0.22 and its two-hundred day simple moving average is $0.22.
Acerus Pharmaceuticals Company Profile
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia.
See Also
- Five stocks we like better than Acerus Pharmaceuticals
- What Are Growth Stocks and Investing in Them
- The Average 401k Balance by Age Explained
- Consumer Staples Stocks, Explained
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- How to Invest in Biotech Stocks
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Acerus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acerus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.